الأعمال والاقتصاد
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
المصدر: Business News · نُشر
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
أخبار ذات صلة

Children are not colorblind: Why early conversations about race are essential
Discussing racism with children can seem daunting to parents, caregivers and educators for several reasons. Often, it can feel uncomfortable talking about people's differences; conversations about racism reveal implicit biases and, for some, immense privilege.
Phys.org - latest science and technology news stories ·

New study: Children who grow up in poverty are 5 times more likely to be poor young adults
About 757,000 Australian children younger than 15 lived in poverty in 2022–23—more than all the people living in the cities of Geelong, Newcastle and Wollongong combined.
Phys.org - latest science and technology news stories ·

Children can fear snakes and still love nature, new study finds
Vanessa Woods' latest research didn't begin in a laboratory or during fieldwork. It began at home, with her own children.
Phys.org - latest science and technology news stories ·
Children’s Place files for bankruptcy protection, seeks buyer
The Children's Place has filed for chapter 11 bankruptcy protection and is seeking bids from potential new owners by Dec. 9.
Business News ·
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Business News ·